INR 152.51
(-2.26%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.12 Billion INR | -37.92% |
2022 | 1.79 Billion INR | 14.4% |
2021 | 1.56 Billion INR | 43.3% |
2020 | 1.09 Billion INR | -0.07% |
2019 | 1.09 Billion INR | -8.9% |
2018 | 1.19 Billion INR | 1.06% |
2017 | 1.18 Billion INR | -5.78% |
2016 | 1.25 Billion INR | 15.81% |
2015 | 1.08 Billion INR | 7.0% |
2014 | 1.01 Billion INR | 8.25% |
2013 | 939.09 Million INR | 11.81% |
2012 | 839.93 Million INR | 190.71% |
2011 | 288.92 Million INR | 14551.47% |
2010 | 1.97 Million INR | -93.16% |
2009 | 28.82 Million INR | 286.95% |
2008 | 7.45 Million INR | -63.18% |
2007 | 20.23 Million INR | -35.79% |
2006 | 31.51 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 309.53 Million INR | 15.35% |
2024 Q2 | 606.98 Million INR | 9.43% |
2023 Q2 | 535.07 Million INR | 9.51% |
2023 Q3 | 510.58 Million INR | -4.58% |
2023 Q4 | 268.34 Million INR | -47.44% |
2023 FY | 1.11 Billion INR | -37.92% |
2023 Q1 | 488.61 Million INR | -60.24% |
2022 Q1 | 469.27 Million INR | 26.23% |
2022 Q2 | 447.02 Million INR | -4.74% |
2022 Q4 | 1.22 Billion INR | 536.85% |
2022 Q3 | 192.94 Million INR | -56.84% |
2022 FY | 1.79 Billion INR | 14.4% |
2021 Q4 | 371.77 Million INR | -10.02% |
2021 FY | 1.56 Billion INR | 43.3% |
2021 Q1 | 328.69 Million INR | 12.78% |
2021 Q2 | 451.03 Million INR | 37.22% |
2021 Q3 | 413.14 Million INR | -8.4% |
2020 Q4 | 291.43 Million INR | -2.03% |
2020 Q1 | 213.11 Million INR | -14.41% |
2020 Q3 | 297.46 Million INR | 2.62% |
2020 FY | 1.09 Billion INR | -0.07% |
2020 Q2 | 289.88 Million INR | 36.02% |
2019 Q3 | 279.9 Million INR | -0.97% |
2019 Q1 | 281.08 Million INR | -3.9% |
2019 Q4 | 248.99 Million INR | -11.04% |
2019 FY | 1.09 Billion INR | -8.9% |
2019 Q2 | 282.63 Million INR | 0.55% |
2018 Q2 | 303.85 Million INR | -2.51% |
2018 FY | 1.19 Billion INR | 1.06% |
2018 Q1 | 311.68 Million INR | 4.35% |
2018 Q3 | 291.29 Million INR | -4.14% |
2018 Q4 | 292.47 Million INR | 0.41% |
2017 Q2 | 275.3 Million INR | -0.1% |
2017 Q3 | 315.71 Million INR | 14.68% |
2017 Q4 | 298.68 Million INR | -5.39% |
2017 FY | 1.18 Billion INR | -5.78% |
2017 Q1 | 275.56 Million INR | -24.41% |
2016 Q1 | 320.79 Million INR | 13.09% |
2016 FY | 1.25 Billion INR | 15.81% |
2016 Q4 | 364.55 Million INR | 10.45% |
2016 Q3 | 330.06 Million INR | 7.72% |
2016 Q2 | 306.4 Million INR | -4.48% |
2015 Q2 | 298.8 Million INR | 14.44% |
2015 Q1 | 261.09 Million INR | -31.71% |
2015 FY | 1.08 Billion INR | 7.0% |
2015 Q4 | 283.64 Million INR | -3.21% |
2015 Q3 | 293.06 Million INR | -1.92% |
2014 Q4 | 382.36 Million INR | 156.47% |
2014 Q3 | 149.08 Million INR | -38.87% |
2014 Q1 | 239.14 Million INR | 0.0% |
2014 FY | 1.01 Billion INR | 8.25% |
2014 Q2 | 243.89 Million INR | 1.99% |
2013 FY | 939.09 Million INR | 11.81% |
2012 Q3 | 67.06 Million INR | -1.61% |
2012 Q1 | 26.7 Million INR | 0.0% |
2012 FY | 839.93 Million INR | 190.71% |
2012 Q4 | 678 Million INR | 911.03% |
2012 Q2 | 68.16 Million INR | 155.19% |
2011 FY | 288.92 Million INR | 14551.47% |
2010 FY | 1.97 Million INR | -93.16% |
2009 FY | 28.82 Million INR | 286.95% |
2008 FY | 7.45 Million INR | -63.18% |
2007 FY | 20.23 Million INR | -35.79% |
2006 FY | 31.51 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -7820.903% |
Aarti Drugs Limited | 1.16 Billion INR | 3.57% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 63.382% |
Ajanta Pharma Limited | 30.46 Billion INR | 96.304% |
Alembic Limited | 872.45 Million INR | -29.038% |
Alkem Laboratories Limited | 32.83 Billion INR | 96.571% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 92.906% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 54.486% |
Bal Pharma Limited | 555.62 Million INR | -102.618% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -16407.302% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 20.675% |
Brooks Laboratories Limited | 51.18 Million INR | -2099.683% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | -147.11% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 48.227% |
Divi's Laboratories Limited | 14.17 Billion INR | 92.055% |
Eris Lifesciences Limited | 4.94 Billion INR | 77.224% |
Granules India Limited | 10.31 Billion INR | 89.083% |
Ind-Swift Limited | 946.56 Million INR | -18.935% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -156.709% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 92.389% |
Jubilant Pharmova Limited | 14.45 Billion INR | 92.211% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -172.969% |
Medicamen Biotech Limited | 335.16 Million INR | -235.892% |
Medico Remedies Limited | 59.67 Million INR | -1786.549% |
Wockhardt Limited | 8.48 Billion INR | 86.724% |
Orchid Pharma Limited | 800.77 Million INR | -40.589% |
RPG Life Sciences Limited | 1.63 Billion INR | 31.165% |
Shilpa Medicare Limited | 3.33 Billion INR | 66.235% |
Sigachi Industries Limited | 579.88 Million INR | -94.141% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 55.922% |
Unichem Laboratories Limited | 6.72 Billion INR | 83.262% |
Vaishali Pharma Limited | 84.02 Million INR | -1239.773% |
Wanbury Limited | 978.96 Million INR | -14.999% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.101% |
FDC Limited | 3.49 Billion INR | 67.832% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 46.238% |
Bajaj HealthCare Limited | 985.34 Million INR | -14.254% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 98.826% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 90.329% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 47.001% |
Laurus Labs Limited | 11.9 Billion INR | 90.547% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -593.96% |
Nectar Lifesciences Limited | 932.7 Million INR | -20.703% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -1831.44% |
Hester Biosciences Limited | 908.84 Million INR | -23.872% |
Ipca Laboratories Limited | 18.98 Billion INR | 94.071% |
Venus Remedies Limited | 1.91 Billion INR | 41.251% |
ZIM Laboratories Limited | 1.01 Billion INR | -11.129% |
Aurobindo Pharma Limited | 55.65 Billion INR | 97.977% |
Morepen Laboratories Limited | 1.98 Billion INR | 43.355% |
Neuland Laboratories Limited | 2.92 Billion INR | 61.574% |
Sequent Scientific Limited | 2.9 Billion INR | 61.204% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 19.746% |
Valiant Laboratories Limited | 138.02 Million INR | -715.624% |
Windlas Biotech Limited | 1 Billion INR | -11.852% |
Hikal Limited | 4.46 Billion INR | 74.779% |
Innova Captab Limited | 931.03 Million INR | -20.92% |
Procter & Gamble Health Limited | 2.99 Billion INR | 62.416% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 48.851% |
Mankind Pharma Limited | 29.27 Billion INR | 96.154% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 97.602% |
Sakar Healthcare Limited | 204.07 Million INR | -451.648% |
Albert David Limited | 1.02 Billion INR | -9.711% |
Lupin Limited | 125.09 Billion INR | 99.1% |
Gufic Biosciences Limited | 1.18 Billion INR | 5.123% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.27% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -4.805% |
Syncom Formulations (India) Limited | 345.63 Million INR | -225.721% |
Piramal Enterprises Limited | 63.65 Billion INR | 98.231% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 94.745% |
NATCO Pharma Limited | 10.05 Billion INR | 88.807% |
Suven Life Sciences Limited | 109.75 Million INR | -925.784% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -2339.115% |
Strides Pharma Science Limited | 9.16 Billion INR | 87.713% |
Indoco Remedies Limited | 12.06 Billion INR | 90.666% |
Alpa Laboratories Limited | 127.38 Million INR | -783.811% |
Lasa Supergenerics Limited | 291.17 Million INR | -286.641% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 63.41% |